权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Mechanisms in primary nociceptors that drive ongoing activity and ongoing pain

初级伤害感受器驱动持续活动和持续疼痛的机制

基本信息

批准号：
10381714
负责人：
EDGAR T. WALTERS
金额：
$ 42.3万
依托单位：
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-04-15 至 2024-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10381714
关键词：
Action Potentials Acute Acute Pain Afferent Neurons Analgesics Attention Automobile Driving C Fiber Capsaicin Cells Chemosensitization Chronic Clinical Cyclic AMP Dependence Distress Dose Drug usage Electrophysiology (science)Fiber Forskolin Foundations Frequencies Freund&apos s Adjuvant Generations Hyperalgesia Inflammation Inflammatory Injections Intervention Investigation Ion Channel Ions Knowledge Link Mediator of activation protein Medical Membrane Potentials Modeling Mus Nature Neurons Neuropathy Nociception Nociceptors Opioid Pain Pathway interactions Peripheral Persistent pain Pharmaceutical Preparations Pharmacology Potassium Channel Procedures Property Rattus Reporting Resistance Rest Risk Role Serotonin Signal Transduction Spinal Ganglia Spinal cord injury Structure of trigeminal ganglion TRPV1 gene Testing Transgenic Mice Transgenic Organisms Translating allodynia behavior test chronic pain defined contribution economic cost effective therapy in vitro activity in vivo in vivo evaluation inhibitor novel pre-clinical prevent side effect social spinal nerve posterior root virtual voltage

项目摘要

Project Summary The long-term objective of this project is to discover novel, highly targeted approaches for treating ongoing pain by defining critical mechanisms of ongoing activity (OA) in primary nociceptors that drive this pain. Recent discoveries revealed that the OA generated spontaneously in probable nociceptors and linked to ongoing pain after spinal cord injury (SCI) is associated with all three electrophysiological alterations that, in principle, can promote OA. These are depolarization of resting membrane potential (RMP), reduced voltage threshold for action potentials (APs), and increased frequency of large, transient, depolarizing spontaneous fluctuations (DSFs). Two extrinsic mediators related to inflammation, serotonin (5-HT) and capsaicin (mimicking endogenous TRPV1 activators), also promote OA, in large part by enhancing DSFs. Virtually nothing is known about mechanisms underlying large DSFs. Three specific aims will test hypotheses about DSF generation and potentiation, employing whole cell patch recording, stimulation by Ca2+ uncaging, pharmacological and transgenic approaches, in vivo recording, and behavioral tests. Aim 1 will define ion conductance and cell signaling (Ca2+ and cAMP) contributions to the acute generation of large DSFs, taking advantage of the ability of 5-HT, forskolin, and capsaicin to rapidly stimulate large DSFs, using naïve rats and transgenic mice. The focus will include HCN channels, T-type Ca2+ channels, and Nav1.8 channels. Special attention will be paid to TRPC4/5 channels, which are important for OA and have unusual properties that account for unique features of large DSFs. Aim 2 will define ion conductances and cell signals that promote large DSF generation in chronic SCI and in a subacute peripheral inflammation model (hindpaw injection of complete Freund's adjuvant - CFA). The channels found in Aim 1 to be important for large DSFs will be tested for altered contributions and expression in each model. Alterations promoting OA are predicted to be shared in these models (and thus to potentially drive many forms of ongoing pain). Aim 3 will test the prediction that combined interventions selectively blocking large DSFs and elevating AP threshold will reduce ongoing pain. A novel analgesic strategy will be tested, which combines a drug that prevents large DSF generation (a TRPC4/5 blocker) with a drug that selectively elevates AP threshold in nociceptors (a Nav1.8 blocker). The combination should efficiently suppress nociceptor OA and consequent ongoing pain at doses lower than required to observe any effect on ongoing pain from either drug alone. This prediction will be tested in vivo both on C-fiber OA recorded from dorsal roots of anesthetized rats and on ongoing pain in SCI rats and in rat and mouse CFA models. This targeted approach could lay the foundation for new treatments for severe ongoing pain that have relatively few side effects and provide an alternative to opioids, with their attendant risks.

项目总结